Could Decreased Reporting of Suspected Adverse Reactions Generate Future Safety Concerns?

Hosp Pharm. 2022 Aug;57(4):419-421. doi: 10.1177/00185787211069040. Epub 2022 Jan 7.

Authors

Francesco Ferrara¹, Carolina Mancaniello¹, Livia Nava², Alessandra Salierno¹, Raffaele Casillo¹, Ugo Trama³, Eduardo Nava¹, Antonio Vitiello⁴

Affiliations

¹ Asl Napoli 3 Sud, Nola, Naples, Italy.
² Asl Napoli 2 Nord, Frattamaggiore, Naples, Italy.
³ Drug Policies, Campania Region, Naples, Italy.
⁴ Usl Umbria 1, Perugia, Italy.

No abstract available